Search

everythinglearnresearchcommunity

for

Search:↓

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

There might be a skin condition related to COVID-19.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

The COVID-19 pandemic caused a drop in phototherapy for skin conditions, with only 40% of vitiligo and psoriasis patients returning after a hospital closure in Taiwan.

Androgenetic alopecia severity does not affect COVID-19 severity.

COVID-19 reinfection may trigger alopecia areata.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Hair loss doesn't affect COVID-19 severity.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Vaccination and timely treatment reduce the risk of long COVID.